| Financial Year |
March 31 2023 |
| Monetary Funds |
368,085,471.95 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
13,876,493.85 |
| Accounts Receivable |
53,103,775.44 |
| Advances to Suppliers |
9,507,370.08 |
| Other Receivables |
27,316,720.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
111,155,898.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,619,197.13 |
| Total Current Assets |
591,683,365.23 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,881,272.73 |
| Investment Properties |
51,248,748.50 |
| Fixed Assetes |
13,112,474.87 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
9,696,023.29 |
| R&D expenses |
-- |
| Goodwill |
76,333,074.25 |
| Long-Term Deferred and Prepaid Expenses |
2,892,059.50 |
| Deferred Income Tax Assets |
5,404,957.48 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
169,207,002.63 |
| Total Assets |
760,890,367.86 |
| Short-Term Loans |
27,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
5,367,550.85 |
| Accounts Payable |
13,101,348.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,823,892.22 |
| Taxes Payable |
5,521,626.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,551,463.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,110,062.41 |
| Other Current Liabilities |
442,148.86 |
| Sub-Total of Current Liabilities |
70,023,773.12 |
| Long-term Loans |
6,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
164,092.34 |
| Deferred Income Tax Liabilities |
1,237,083.60 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,090,556.26 |
| Total Liabilities |
79,114,329.38 |
| Paid-In Capital(Or Share Stock) |
236,000,000.00 |
| Capital Surplus |
276,124,384.02 |
| Surplus Reserve |
937,577.61 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
156,871,440.34 |
| Minority Stockholder's Interest |
9,366,016.12 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
672,410,022.36 |
| Owner's Equity（Stockholder's Equity） |
681,776,038.48 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
760,890,367.86 |
